A citation-based method for searching scientific literature

Nan M Solomons, Amanda E Lamb, Frances L Lucas, Eileen F McDonald, Susan Miesfeldt. Telemed J E Health 2018
Times Cited: 18







List of co-cited articles
87 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Goals, benefits, and outcomes of genetic counseling: client and genetic counselor assessment.
B A Bernhardt, B B Biesecker, C L Mastromarino. Am J Med Genet 2000
99
5

Satisfaction with genetic counseling: dimensions and measurement.
S Shiloh, O Avdor, R M Goodman. Am J Med Genet 1990
91
5

The impact of population based screening for carriers of cystic fibrosis.
H Bekker, G Denniss, M Modell, M Bobrow, T Marteau. J Med Genet 1994
70
5

The eXtraordinarY Kids Clinic: an interdisciplinary model of care for children and adolescents with sex chromosome aneuploidy.
Nicole Tartaglia, Susan Howell, Rebecca Wilson, Jennifer Janusz, Richard Boada, Sydney Martin, Jacqueline B Frazier, Michelle Pfeiffer, Karen Regan, Sarah McSwegin,[...]. J Multidiscip Healthc 2015
19
5

Evolution of genetic assessment for BRCA-associated gynaecologic malignancies: a Canadian multisociety roadmap.
Jeanna M McCuaig, Tracy L Stockley, Patricia Shaw, Michael Fung-Kee-Fung, Alon D Altman, James Bentley, Marcus Q Bernardini, Beatrice Cormier, Hal Hirte, Katharina Kieser,[...]. J Med Genet 2018
18
5


Utilization and Outcomes of BRCA Genetic Testing and Counseling in a National Commercially Insured Population: The ABOUT Study.
Joanne Armstrong, Michele Toscano, Nancy Kotchko, Sue Friedman, Marc D Schwartz, Katherine S Virgo, Kristian Lynch, James E Andrews, Claudia X Aguado Loi, Joseph E Bauer,[...]. JAMA Oncol 2015
76
5

The Angelina Jolie effect: how high celebrity profile can have a major impact on provision of cancer related services.
D Gareth Evans, Julian Barwell, Diana M Eccles, Amanda Collins, Louise Izatt, Chris Jacobs, Alan Donaldson, Angela F Brady, Andrew Cuthbert, Rachel Harrison,[...]. Breast Cancer Res 2014
178
5

Cost-effectiveness of routine screening for Lynch syndrome in endometrial cancer patients up to 70years of age.
Anne Goverde, Manon Cw Spaander, Helena C van Doorn, Hendrikus J Dubbink, Ans Mw van den Ouweland, Carli M Tops, Sjarlot G Kooi, Judith de Waard, Robert F Hoedemaeker, Marco J Bruno,[...]. Gynecol Oncol 2016
27
5

Universal Screening for Mismatch-Repair Deficiency in Endometrial Cancers to Identify Patients With Lynch Syndrome and Lynch-like Syndrome.
Jaclyn C Watkins, Eric J Yang, Michael G Muto, Colleen M Feltmate, Ross S Berkowitz, Neil S Horowitz, Sapna Syngal, Matthew B Yurgelun, Anu Chittenden, Jason L Hornick,[...]. Int J Gynecol Pathol 2017
49
5

Population screening for BRCA1/BRCA2 mutations: lessons from qualitative analysis of the screening experience.
Sari Lieberman, Amnon Lahad, Ariela Tomer, Carmit Cohen, Ephrat Levy-Lahad, Aviad Raz. Genet Med 2017
18
5

Impact of Panel Gene Testing for Hereditary Breast and Ovarian Cancer on Patients.
Heidi S Lumish, Hallie Steinfeld, Carrie Koval, Donna Russo, Elana Levinson, Julia Wynn, James Duong, Wendy K Chung. J Genet Couns 2017
59
5

Implementation of routine screening for Lynch syndrome in university and safety-net health system settings: successes and challenges.
Evelyn Marquez, Zhuo Geng, Sarah Pass, Pia Summerour, Linda Robinson, Venetia Sarode, Samir Gupta. Genet Med 2013
19
5


Selective Versus Universal Screening for Lynch Syndrome: A Six-Year Clinical Experience.
Trilokesh D Kidambi, Amie Blanco, Megan Myers, Peggy Conrad, Kate Loranger, Jonathan P Terdiman. Dig Dis Sci 2015
24
5

Population genetic testing for cancer susceptibility: founder mutations to genomes.
William D Foulkes, Bartha Maria Knoppers, Clare Turnbull. Nat Rev Clin Oncol 2016
61
5

Oncologists' and cancer patients' views on whole-exome sequencing and incidental findings: results from the CanSeq study.
Stacy W Gray, Elyse R Park, Julie Najita, Yolanda Martins, Lara Traeger, Elizabeth Bair, Joshua Gagne, Judy Garber, Pasi A Jänne, Neal Lindeman,[...]. Genet Med 2016
68
5

Universal screening for Lynch syndrome among patients with colorectal cancer: patient perspectives on screening and sharing results with at-risk relatives.
Jessica Ezzell Hunter, Kathleen A Arnold, Jennifer E Cook, Jamilyn Zepp, Marian J Gilmore, Alan F Rope, James V Davis, Kellene M Bergen, Elizabeth Esterberg, Kristin R Muessig,[...]. Fam Cancer 2017
7
14

Patient outcomes associated with group and individual genetic counseling formats.
Erin Rothwell, Wendy Kohlmann, Kory Jasperson, Amanda Gammon, Bob Wong, Anita Kinney. Fam Cancer 2012
15
6

Finding all BRCA pathogenic mutation carriers: best practice models.
Nicoline Hoogerbrugge, Marjolijn Cj Jongmans. Eur J Hum Genet 2016
7
14

Errors in delivery of cancer genetics services: implications for practice.
Karina L Brierley, Danielle Campfield, Whitney Ducaine, Lindsay Dohany, Talia Donenberg, Kristen Shannon, Robin C Schwartz, Ellen T Matloff. Conn Med 2010
65
5

BRCA1/2 testing in newly diagnosed breast and ovarian cancer patients without prior genetic counselling: the DNA-BONus study.
Hildegunn Høberg-Vetti, Cathrine Bjorvatn, Bent E Fiane, Turid Aas, Kathrine Woie, Helge Espelid, Tone Rusken, Hans Petter Eikesdal, Wenche Listøl, Marianne T Haavind,[...]. Eur J Hum Genet 2016
35
5

Impact of an immunohistochemistry-based universal screening protocol for Lynch syndrome in endometrial cancer on genetic counseling and testing.
Antonina I Frolova, Sheri A Babb, Emily Zantow, Andrea R Hagemann, Matthew A Powell, Premal H Thaker, Feng Gao, David G Mutch. Gynecol Oncol 2015
28
5

Mainstreaming cancer genetics: A model integrating germline BRCA testing into routine ovarian cancer clinics.
Maira Kentwell, Eryn Dow, Yoland Antill, C David Wrede, Orla McNally, Emily Higgs, Anne Hamilton, Sumitra Ananda, Geoffrey J Lindeman, Clare L Scott. Gynecol Oncol 2017
54
5

Universal tumor screening for Lynch syndrome: Assessment of the perspectives of patients with colorectal cancer regarding benefits and barriers.
Jessica Ezzell Hunter, Jamilyn M Zepp, Mari J Gilmore, James V Davis, Elizabeth J Esterberg, Kristin R Muessig, Susan K Peterson, Sapna Syngal, Louise S Acheson, Georgia L Wiesner,[...]. Cancer 2015
22
5

Prevalence of deleterious germline variants in risk genes including BRCA1/2 in consecutive ovarian cancer patients (AGO-TR-1).
Philipp Harter, Jan Hauke, Florian Heitz, Alexander Reuss, Stefan Kommoss, Frederik Marmé, André Heimbach, Katharina Prieske, Lisa Richters, Alexander Burges,[...]. PLoS One 2017
41
5

Association of patient navigation with care coordination in an Lynch syndrome screening program.
Susan Miesfeldt, W Gregory Feero, Frances L Lucas, Karen Rasmussen. Transl Behav Med 2018
5
20

Screening for mismatch repair deficiency in colorectal cancer: data from three academic medical centers.
Grainne M O'Kane, Éanna Ryan, Terri P McVeigh, Ben Creavin, John Mp Hyland, Diarmuid P O'Donoghue, Denise Keegan, Robert Geraghty, Delia Flannery, Carmel Nolan,[...]. Cancer Med 2017
19
5

Direct-to-patient disclosure of results of mismatch repair screening for Lynch syndrome via electronic personal health record: a feasibility study.
Michael J Hall, Meagan M Herda, Elizabeth A Handorf, Christina C Rybak, Cindy A Keleher, Mark Siemon, Mary B Daly. Genet Med 2014
11
9

Universal BRCA1/BRCA2 Testing for Ovarian Cancer Patients is Welcomed, but with Care: How Women and Staff Contextualize Experiences of Expanded Access.
Hannah Shipman, Samantha Flynn, Carey F MacDonald-Smith, James Brenton, Robin Crawford, Marc Tischkowitz, Nicholas J Hulbert-Williams. J Genet Couns 2017
8
12

When knowledge of a heritable gene mutation comes out of the blue: treatment-focused genetic testing in women newly diagnosed with breast cancer.
B Meiser, V F Quinn, M Gleeson, J Kirk, K M Tucker, B Rahman, C Saunders, K J Watts, M Peate, E Geelhoed,[...]. Eur J Hum Genet 2016
10
10

Universal Point of Care Testing for Lynch Syndrome in Patients with Upper Tract Urothelial Carcinoma.
Michael J Metcalfe, Firas G Petros, Priya Rao, Maureen E Mork, Lianchun Xiao, Russell R Broaddus, Surena F Matin. J Urol 2018
25
5

Consequences of universal MSI/IHC in screening ENDOMETRIAL cancer patients for Lynch syndrome.
Brittany A L Batte, Amanda S Bruegl, Molly S Daniels, Kari L Ring, Katherine M Dempsey, Bojana Djordjevic, Rajyalakshmi Luthra, Bryan M Fellman, Karen H Lu, Russell R Broaddus. Gynecol Oncol 2014
56
5

Lessons learnt from implementation of a Lynch syndrome screening program for patients with gynaecological malignancy.
Fedaa Najdawi, Ashley Crook, Jayne Maidens, Christopher McEvoy, Andrew Fellowes, Justine Pickett, Musei Ho, David Nevell, Kirsten McIlroy, Amy Sheen,[...]. Pathology 2017
23
5

Mainstreamed genetic testing for women with ovarian cancer: first-year experience.
Belinda Rahman, Anne Lanceley, Rebecca S Kristeleit, Jonathan A Ledermann, Michelle Lockley, Mary McCormack, Tim Mould, Lucy Side. J Med Genet 2019
20
5

Evaluation of group genetic counseling for hereditary breast and ovarian cancer.
Yolanda Ridge, Karen Panabaker, Mary McCullum, Cheryl Portigal-Todd, Jenna Scott, Barbara McGillivray. J Genet Couns 2009
16
6

Breast and ovarian cancer: a new model for educating women.
Beverly Mangerich, Jaynelle F Stichler. Nurs Womens Health 2008
1
100

Multi-disciplinary summit on genetics services for women with gynecologic cancers: A Society of Gynecologic Oncology White Paper.
Leslie M Randall, Bhavana Pothuri, Elizabeth M Swisher, John P Diaz, Adam Buchanan, Catherine T Witkop, C Bethan Powell, Ellen Blair Smith, Mark E Robson, Jeff Boyd,[...]. Gynecol Oncol 2017
51
5

Implementation of universal microsatellite instability and immunohistochemistry screening for diagnosing lynch syndrome in a large academic medical center.
Brandie Heald, Thomas Plesec, Xiuli Liu, Rish Pai, Deepa Patil, Jessica Moline, Richard R Sharp, Carol A Burke, Matthew F Kalady, James Church,[...]. J Clin Oncol 2013
116
5

Genetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized Medicine.
Jeffrey N Weitzel, Kathleen R Blazer, Deborah J MacDonald, Julie O Culver, Kenneth Offit. CA Cancer J Clin 2011
143
5

Delivering widespread BRCA testing and PARP inhibition to patients with ovarian cancer.
Angela George, Stan Kaye, Susana Banerjee. Nat Rev Clin Oncol 2017
83
5

Streamlined genetic education is effective in preparing women newly diagnosed with breast cancer for decision making about treatment-focused genetic testing: a randomized controlled noninferiority trial.
Veronica F Quinn, Bettina Meiser, Judy Kirk, Kathy M Tucker, Kaaren J Watts, Belinda Rahman, Michelle Peate, Christobel Saunders, Elizabeth Geelhoed, Margaret Gleeson,[...]. Genet Med 2017
18
5

Modes of delivery of genetic testing services and the uptake of cancer risk management strategies in BRCA1 and BRCA2 carriers.
T Pal, J-H Lee, A Besharat, Z Thompson, A N A Monteiro, C Phelan, J M Lancaster, K Metcalfe, T A Sellers, S Vadaparampil,[...]. Clin Genet 2014
22
5

Identifying Needs: a Qualitative Study of women's Experiences Regarding Rapid Genetic Testing for Hereditary Breast and Ovarian Cancer in the DNA BONus Study.
Mirjam Tonheim Augestad, Hildegunn Høberg-Vetti, Cathrine Bjorvatn, Ragnhild Johanne Tveit Sekse. J Genet Couns 2017
14
7

Distress among women receiving uninformative BRCA1/2 results: 12-month outcomes.
Suzanne C O'Neill, Christine Rini, Rachel E Goldsmith, Heiddis Valdimarsdottir, Lawrence H Cohen, Marc D Schwartz. Psychooncology 2009
69
5


Universal molecular screening does not effectively detect Lynch syndrome in clinical practice.
Beatrice Brennan, Christine T Hemmings, Ian Clark, Desmond Yip, Mitali Fadia, Douglas R Taupin. Therap Adv Gastroenterol 2017
12
8

High Satisfaction and Low Distress in Breast Cancer Patients One Year after BRCA-Mutation Testing without Prior Face-to-Face Genetic Counseling.
Aisha S Sie, Liesbeth Spruijt, Wendy A G van Zelst-Stams, Arjen R Mensenkamp, Marjolijn J L Ligtenberg, Han G Brunner, Judith B Prins, Nicoline Hoogerbrugge. J Genet Couns 2016
20
5

Evaluation of a Streamlined Oncologist-Led BRCA Mutation Testing and Counseling Model for Patients With Ovarian Cancer.
Nicoletta Colombo, Gloria Huang, Giovanni Scambia, Eva Chalas, Sandro Pignata, James Fiorica, Linda Van Le, Sharad Ghamande, Santiago González-Santiago, Isabel Bover,[...]. J Clin Oncol 2018
45
5

More breast cancer patients prefer BRCA-mutation testing without prior face-to-face genetic counseling.
Aisha S Sie, Wendy A G van Zelst-Stams, Liesbeth Spruijt, Arjen R Mensenkamp, Marjolijn J L Ligtenberg, Han G Brunner, Judith B Prins, Nicoline Hoogerbrugge. Fam Cancer 2014
30
5


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.